Abstracts tagged "Comorbidity"

Abstract Number: 1231 • 2016 ACR/ARHP Annual Meeting
Impact of Comorbidity on Health-Related Quality of Life and Healthcare Expenditure in Patients with Rheumatoid Arthritis
Eric Nyarko¹ and J An², ¹College of Pharmacy, Western University of Health Sciences, Pomona, CA, ²Western University of Health Sciences, Pomona, CA
Background/Purpose: Rheumatoid Arthritis (RA) is known to be associated with an increased risk of comorbidity, premature mortality, and disability. We investigated the effect of comorbidity…
Abstract Number: 1235 • 2016 ACR/ARHP Annual Meeting
Healthcare Utilization and Multimorbidities Among Adult Patients with Juvenile Idiopathic Arthritis
Nina Mars¹, Anne M Kerola², Markku J Kauppi^3,4, Outi Elonheimo^5,6, Santeri Huvinen^5,6 and Tuulikki Sokka-Isler⁷, ¹University of Helsinki, Helsinki, Finland, ²Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland, ³School of Medicine, University of Tampere, Tampere, Finland, ⁴Department of Rheumatology, Päijät-Häme Central Hospital, Lahti, Finland, ⁵FCG Finnish Consulting Group Ltd., Helsinki, Finland, ⁶Network of Academic Health Centres, Department of Medicine, University of Helsinki, Helsinki, Finland, ⁷Rheumatology, Jyvaskyla Central Hospital, Jyvaskyla, Finland
Background/Purpose: Active juvenile idiopathic arthritis (JIA) is commonly associated with high healthcare costs in children. The disabling consequences and multimorbidities often manifest, however, in adulthood.…
Abstract Number: 1480 • 2016 ACR/ARHP Annual Meeting
Determination of the Lipid Profile in Active Disease Leads to Incorrect Cardiovascular Risk Prediction in Early Rheumatoid Arthritis Patients
Samina A. Turk¹, Dirkjan van Schaardenburg^1,2, Willem F. Lems^1,3 and Mike T. Nurmohamed^1,3, ¹Rheumatology, Amsterdam Rheumatology and immunology Center, location Reade, Amsterdam, Netherlands, Amsterdam, Netherlands, ²Rheumatology, Amsterdam Rheumatology and immunology Center, location Academic Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, ³Rheumatology, Amsterdam Rheumatology and immunology Center, VU University medical center, Amsterdam, Netherlands
Background/Purpose: Rheumatoid arthritis (RA) is associated with increased cardiovascular morbidity and mortality. This cardiovascular risk is mainly determined by the lipid profile, which may change…
Abstract Number: 1552 • 2016 ACR/ARHP Annual Meeting
The Association of Fatigue, Comorbidities and Anti Rheumatic Drugs in Rheumatoid Arthritis: Results from French Cohort Study of Comorbidities
Anne Tournadre¹, Bruno Pereira², Laure Gossec³, Martin Soubrier⁴ and Maxime Dougados⁵, ¹Rheumatology, UNH-UMR 1019 INRA University of Auvergne and Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, ²Biostatistics unit (DRCI), CHU Gabriel Montpied, Clermont-Ferrand, France, ³Sorbonne Universités, UPMC University Paris 06, Paris, France, Paris, France, ⁴Rheumatology, Department of Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, ⁵Paris-Descartes University, Paris, France
Background/Purpose: The mechanisms of fatigue in rheumatoid arthritis (RA) are still unclear and the effect of antirheumatic drugs on fatigue not fully established. Objectives: To…
Abstract Number: 1770 • 2016 ACR/ARHP Annual Meeting
The Impact of Comorbidities on Quality of Life in Systemic Lupus Erythematosus in the First 10 Years
Murray Urowitz¹, Dafna D Gladman², Nicole Anderson³, Jiandong Su⁴ and The Systemic Lupus International Collaborating Clinics (SLICC) Group , ¹Medicine, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ⁴Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada
The Impact of Comorbidities on Quality of Life in Systemic Lupus Erythematosus in the first 10 years Background/Purpose: The Medical Outcome Survey Short Form…
Abstract Number: 1790 • 2016 ACR/ARHP Annual Meeting
Accrual of Disease Comorbidities over 8 Years in a Multicentre Inception SLE Cohort
Murray Urowitz¹, Dafna D Gladman², Nicole Anderson³, Jiandong Su⁴ and The Systemic Lupus International Collaborating Clinics (SLICC) Group, ¹Medicine, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ⁴Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada
Background/Purpose: The annual accrual of comorbidities in patients with SLE is not well described. We report the annual occurrence of these features in an inception…
Abstract Number: 2348 • 2016 ACR/ARHP Annual Meeting
Does Arthritis in Other Joints and Spine Influence the 1-Year Outcome of Total Hip Replacement? a Prospective European Multicenter Cohort Study Measuring the Influence of Musculoskeletal Morbidity
Joerg Huber¹, Paul Dieppe², Karsten Dreinhoefer³, Klaus-Peter Günther⁴, Georg Ruflin⁵ and Andrew Judge⁶, ¹Orthopedics, Triemli Spital, Zurich, Switzerland, ²Exeter Medical School, University of Exeter, Exeter, United Kingdom, ³Centre of Musculosceletal Surgery, Charité, Charite, Berlin, Berlin, Germany, ⁴University Center of Orthopedics and Traumatology, Technische Universität, Dresden, Germany, ⁵Orthopedics, Kantonsspital Aarau, Aarau, Switzerland, ⁶Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom
Background/Purpose: Whilst arthritis in other affected joints and back pain is known to lead to worse outcomes following total hip replacement surgery, these risk factors…
Abstract Number: 2759 • 2016 ACR/ARHP Annual Meeting
Prevalence of Comorbidities and Risk Factors of Spondyloarthritis in Latin America: A Comparative Study with the General Population: Data from the Multinational ASAS-Comospa Study
WILSON BAUTISTA-MOLANO^1,2, Robert Landewé³, Anna Molto⁴, Rubén Burgos-Vargas⁵, José Antonio Maldonado-Cocco⁶, Rafael Valle-Oñate⁷ and Désirée van der Heijde⁸, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Rheumatology Department, School of Medicine, UMNG / HMC, Bogotá, Colombia, ³Amsterdam Medical Center, Amsterdam, Netherlands, ⁴Hopital Cochin, Paris Descartes University, Paris, France, ⁵Rheumatology, Hospital General de Mexico, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico, ⁶Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁷Rheumatology Department, School of Medicine, UMNG / HMC, Bogota, Colombia, ⁸Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Increased risk of several comorbidities has been reported in spondyloarthritis (SpA). Data and knowledge regarding the prevalence of these comorbidities and risk factors in…
Abstract Number: 2878 • 2015 ACR/ARHP Annual Meeting
Treating Axial Spondyloarthritis to Target: Influence of the Population Characteristics and Comorbidities in Reaching Ankylosing Spondylitis Disease Activity Score (ASDAS) Inactive Disease in a Cohort of Patients Treated with Tnfalpha Inhibitors Agents
Sara Monti, Veronica Codullo, Vittorio Grosso, Silvia Breda, Carlomaurizio Montecucco and Roberto Caporali, Division of Rheumatology, University of Pavia, IRCCS Foundation Policlinico S. Matteo, Pavia, Italy
Background/Purpose: The treat to target strategy (T2T), aiming at inactive disease (ID), has become the recommended approach also in the field of axial-SpA (axSpA) (1). …
Abstract Number: 3086 • 2015 ACR/ARHP Annual Meeting
The Same Multidimensional Patient Health Assessment Questionnaire Used to Assess RAPID3 in Rheumatoid Arthritis, Osteoarthritis and Other Rheumatic Diseases Can Provide Quantitative Clues to Recognize and Document Comorbid Fibromyalgia
Kathryn A. Gibson¹, Annie Huang² and Theodore Pincus², ¹Liverpool Hospital, Liverpool, Australia, ²Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: An MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index Data) is a 2 sided, 1 page questionnaire which is completed by patients in…
Abstract Number: 3119 • 2015 ACR/ARHP Annual Meeting
The Risk of Venous Thromboembolism in Psoriatic Arthritis, Psoriasis and Rheumatoid Arthritis
Alexis Ogdie-Beatty¹, Daniel Shin², Junko Takeshita², Zelma ChiesaFuxench² and Joel Gelfand³, ¹Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, ²University of Pennsylvania, Philadelphia, PA, ³University of Pennsylvania Health System , Philadelphia, PA
Background/Purpose: Venous thromboembolism (VTE), the combined endpoint of deep venous thrombosis (DVT) and pulmonary embolism (PE), is a common and potentially deadly medical problem with…
Abstract Number: 3120 • 2015 ACR/ARHP Annual Meeting
The Prevalence, Incidence and Management of Hypertension, Diabetes and Hyperlipidemia in Psoriatic Arthritis, Psoriasis and Rheumatoid Arthritis
Kashif Jafri¹, Christie M. Bartels², Daniel Shin³ and Alexis Ogdie-Beatty⁴, ¹Department of Medicine, University of Pennsylvania, Philadelphia, PA, ²Medicine, Rheumatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, ³University of Pennsylvania, Philadelphia, PA, ⁴Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA
Background/Purpose: Psoriasis, psoriatic arthritis (PsA), and rheumatoid arthritis (RA) are associated with an increased risk for cardiovascular disease (CVD). While management of traditional CVD risk…
Abstract Number: 3258 • 2015 ACR/ARHP Annual Meeting
Different Perception of Disease Activity in Multimorbid Rheumatoid Arthritis Patients
Helga Radner^1,2, Kazuki Yoshida^1,3, Sara K. Tedeschi⁴, M Frits⁵, C Iannaccone⁶, N Shadick⁷, Michael Weinblatt¹, Daniel Aletaha⁸, Josef S. Smolen⁹ and Daniel H. Solomon¹⁰, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Department of Internal Medicine III; Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ³Department of Epidemiology, Harvard School of Public Health, Boston, MA, ⁴Rheumatology, Brigham & Women's Hospital, Boston, MA, ⁵Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, ⁶Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, ⁷Division of Rheumatology, Immunology & Allergy, Brigham and Women's Hosp, Boston, MA, ⁸Rheumatology, Medical University Vienna, Vienna, Austria, ⁹Dept of Medicine 3, Division of Rheumatology, Medical Univ Vienna, Vienna, Austria, ¹⁰Rheumatology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: The patient rating of global rheumatoid arthritis (RA) disease activity (PtGA) is a key variable in composite measures of disease activity as well as…
Abstract Number: 43 • 2015 ACR/ARHP Annual Meeting
Prevalence and Relevance of Depressive Symptoms in Patients with Rheumatic Diseases
Stefan Kleinert^1,2, Almuth Marx³, Hermann Faller⁴, Martin Feuchtenberger⁵, Christian Kneitz⁶, Stefanie Lehmann³, Hans Peter Tony⁷, Christiane Angermann^3,8, Georg Ertl⁸, Stefan Störk³ and Margret Breunig^3,9, ¹Rheumatologische Schwerpunktpraxis Erlangen, Erlangen, Germany, ²University Hospital Würzburg, Würzburg, Germany, ³Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany, ⁴Abteilung für Medizinische Psychologie und Psychotherapie, University of Würzburg, Würzburg, Germany, ⁵Rheumatologie/Klinische Immunologie, Kreiskliniken Altötting-Burghausen, Burghausen, Germany, ⁶Internal Medicine II, Hospital Südstadt, Rostock, Germany, ⁷Rheumatology / Clinical Immunology, University Hospital Würzburg, Würzburg, Germany, ⁸Dept. of Internal Medicine / Cardiology, University Hospital Würzburg, Würzburg, Germany, ⁹Dept. of Internal Medicine / Cardiology, University Hospital Würzburg, Würzburg, Wuerzburg, Germany
Background/Purpose: Patients with rheumatic diseases (RD) have an increased mortality risk compared to the normal population. The current prospective follow-up study investigated the prevalence of…
Abstract Number: 57 • 2015 ACR/ARHP Annual Meeting
Age, Gender, Racial and Comorbidity Differences Among Systemic Lupus Erythematosus Patients Hospitalized with Ischemic Stroke Compared to the General Population: A Nationwide Analysis
Tapan Mehta¹, Khushboo Sheth², Ronak Soni³, Vishad Sheth⁴, Kathan Mehta⁵ and Christopher Scola⁶, ¹Neurology, University of Connecticut, Farmington, CT, Farmington, CT, ²Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, ³Central Michigan University, Mount Pleasant, MI, ⁴Mercy Catholic Medical Center, Yeadon, PA, ⁵Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, Pittsburgh, PA, ⁶Rheumatology, Hartford Hospital, Hartford, CT
Background/Purpose: To determine if age, gender and racial discrepancies exist, and to determine the occurence of comorbidities among patients hospitalized with ischemic stroke with Systemic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].